Matches in Wikidata for { <http://www.wikidata.org/entity/Q88886463> ?p ?o ?g. }
- Q88886463 description "2018 nî lūn-bûn" @default.
- Q88886463 description "2018年の論文" @default.
- Q88886463 description "2018年学术文章" @default.
- Q88886463 description "2018年学术文章" @default.
- Q88886463 description "2018年学术文章" @default.
- Q88886463 description "2018年学术文章" @default.
- Q88886463 description "2018年学术文章" @default.
- Q88886463 description "2018年学术文章" @default.
- Q88886463 description "2018年學術文章" @default.
- Q88886463 description "2018年學術文章" @default.
- Q88886463 description "2018年學術文章" @default.
- Q88886463 description "2018年學術文章" @default.
- Q88886463 description "2018年學術文章" @default.
- Q88886463 description "2018년 논문" @default.
- Q88886463 description "article científic" @default.
- Q88886463 description "article scientific" @default.
- Q88886463 description "article scientifique" @default.
- Q88886463 description "articol științific" @default.
- Q88886463 description "articolo scientifico" @default.
- Q88886463 description "artigo científico" @default.
- Q88886463 description "artigo científico" @default.
- Q88886463 description "artigo científico" @default.
- Q88886463 description "artikel ilmiah" @default.
- Q88886463 description "artikull shkencor" @default.
- Q88886463 description "artikulong pang-agham" @default.
- Q88886463 description "artykuł naukowy" @default.
- Q88886463 description "artículo científico publicado en 2018" @default.
- Q88886463 description "artículu científicu" @default.
- Q88886463 description "bilimsel makale" @default.
- Q88886463 description "bài báo khoa học" @default.
- Q88886463 description "naučni članak" @default.
- Q88886463 description "scienca artikolo" @default.
- Q88886463 description "scientific article published on 29 May 2018" @default.
- Q88886463 description "scientific article published on 29 May 2018" @default.
- Q88886463 description "scientific article published on 29 May 2018" @default.
- Q88886463 description "teaduslik artikkel" @default.
- Q88886463 description "tieteellinen artikkeli" @default.
- Q88886463 description "tudományos cikk" @default.
- Q88886463 description "vedecký článok" @default.
- Q88886463 description "vetenskaplig artikel" @default.
- Q88886463 description "videnskabelig artikel udgivet 29. maj 2018" @default.
- Q88886463 description "vitenskapelig artikkel" @default.
- Q88886463 description "vitskapeleg artikkel" @default.
- Q88886463 description "vědecký článek" @default.
- Q88886463 description "wetenschappelijk artikel" @default.
- Q88886463 description "wissenschaftlicher Artikel" @default.
- Q88886463 description "επιστημονικό άρθρο" @default.
- Q88886463 description "мақолаи илмӣ" @default.
- Q88886463 description "наукова стаття, опублікована в травні 2018" @default.
- Q88886463 description "научна статия" @default.
- Q88886463 description "научная статья" @default.
- Q88886463 description "научни чланак" @default.
- Q88886463 description "научни чланак" @default.
- Q88886463 description "מאמר מדעי" @default.
- Q88886463 description "مقالة علمية نشرت في 29 مايو 2018" @default.
- Q88886463 description "২৯ মে ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q88886463 description "บทความทางวิทยาศาสตร์" @default.
- Q88886463 description "სამეცნიერო სტატია" @default.
- Q88886463 name "Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors" @default.
- Q88886463 name "Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors" @default.
- Q88886463 type Item @default.
- Q88886463 label "Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors" @default.
- Q88886463 label "Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors" @default.
- Q88886463 prefLabel "Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors" @default.
- Q88886463 prefLabel "Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors" @default.
- Q88886463 P1433 Q88886463-9F934C80-E1AA-4B93-8220-DA31019AF79D @default.
- Q88886463 P1476 Q88886463-FD52025D-4AA7-4FBC-9740-A99F823023FF @default.
- Q88886463 P2093 Q88886463-4E1DA4B4-AEB8-4D94-9728-8552253F09F2 @default.
- Q88886463 P2093 Q88886463-5D1CBA5E-B2C7-4053-BA7E-0614C188B777 @default.
- Q88886463 P2093 Q88886463-773173D8-CCEE-4114-8F9D-2962DD1E1DEC @default.
- Q88886463 P2093 Q88886463-8364948F-70F9-4ABA-B901-DA6ED28248E1 @default.
- Q88886463 P2093 Q88886463-9CE217D6-1DF6-4ADD-B83A-56CD56EC106A @default.
- Q88886463 P2093 Q88886463-B8815E38-E5D6-4F3B-997A-F551CA30248F @default.
- Q88886463 P2093 Q88886463-CA4C8232-EAB0-4F83-9951-956F1E7DC9EB @default.
- Q88886463 P2093 Q88886463-D52075A9-E84F-4030-9AAD-C245AB6A11C7 @default.
- Q88886463 P2860 Q88886463-1F554E68-1472-4669-9B9B-514F2B13ADB9 @default.
- Q88886463 P2860 Q88886463-215C7FFE-4C23-489B-8704-424A4CA84392 @default.
- Q88886463 P2860 Q88886463-23CB3362-0C1F-4B0F-82EE-A4747812F34E @default.
- Q88886463 P2860 Q88886463-31731126-1C9F-42B1-A319-DF3853ABF0F1 @default.
- Q88886463 P2860 Q88886463-504AAB2A-0FB4-4645-A763-5F1E238A8CD8 @default.
- Q88886463 P2860 Q88886463-50D8BF2C-38AE-4E42-867B-E859F7967CA8 @default.
- Q88886463 P2860 Q88886463-52EE6D80-E6ED-43E4-BE81-850C87CCB03D @default.
- Q88886463 P2860 Q88886463-55BF4C22-D942-496C-A3BB-0804C904A6B9 @default.
- Q88886463 P2860 Q88886463-5AFEDFEA-2266-4C05-B260-025AA62445EB @default.
- Q88886463 P2860 Q88886463-5B1833BA-F64B-4A73-BEDE-85E756FA2A3E @default.
- Q88886463 P2860 Q88886463-6A3C4184-029E-4000-9126-B96E4E25B23C @default.
- Q88886463 P2860 Q88886463-7BFAA7E2-4DBD-463D-9110-CFAF7E2563F2 @default.
- Q88886463 P2860 Q88886463-859F3181-5811-4864-BF8D-694050DE5423 @default.
- Q88886463 P2860 Q88886463-8B2879BC-A3B6-45CF-BAE9-31414D51E70E @default.
- Q88886463 P2860 Q88886463-94E3D745-EC8F-4944-ADDC-6A01AEEDCBAC @default.
- Q88886463 P2860 Q88886463-A4BB8B1E-9D75-4E9A-A43D-B782D3CD8792 @default.
- Q88886463 P2860 Q88886463-A9A07262-5201-405E-A9A4-0D2470034D69 @default.
- Q88886463 P2860 Q88886463-B80215B9-7D54-4C60-A9AD-8B409D303AA6 @default.
- Q88886463 P2860 Q88886463-D3CE9695-50D7-401F-A08C-848C9E43137E @default.
- Q88886463 P2860 Q88886463-F2BF3629-9C8C-469B-A9E6-C8CE037FB702 @default.
- Q88886463 P2860 Q88886463-F9AD256E-307A-44EF-BA5B-3214749BF020 @default.
- Q88886463 P304 Q88886463-AE72D3E4-B2C2-4621-A0E7-E54FBD8D4A9C @default.
- Q88886463 P31 Q88886463-B45A6D42-ECED-4D5E-BF56-5B1625C685A3 @default.
- Q88886463 P356 Q88886463-A2AD91A8-5395-4655-AEC8-F4A3D98AE4BD @default.
- Q88886463 P433 Q88886463-88B6EC5C-4583-4891-95D7-508AB39B629E @default.